Dako, Amgen to develop new diagnostic test for cancer therapy
In January 2012, Dako has entered into a contract with Amgen introducing a new business model which supports the concurrent development of drug and diagnostics for a rare
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.